Hypersensitive Joint Reaction After Etanercept Treatment in a Patient with Juvenile Rheumatoid Arthritis

被引：2
作者：
Guo, Mindy Ming-Huey
Yang, Kuender D. [2 ]
Yu, Hong-Ren [1 ]
Kuo, Ho-Chang [1 ,3 ]
机构：
[1] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Pediat, Div Allergy Immunol & Rheumatol, Kaohsiung, Taiwan
[2] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Res Dept, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 03期
关键词：
IDIOPATHIC ARTHRITIS; CHILDREN; SAFETY; EFFICACY; REGISTRY;
D O I：
10.3899/jrheum.100751
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：577 / 579
页数：3
相关论文
共 50 条
  • [31] Etanercept treatment in rheumatoid arthritis patients with chronic kidney failure on predialysis
    Cho, Soo-Kyung
    Sung, Yoon-Kyoung
    Park, Songree
    Bae, Sang-Cheol
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) : 1519 - 1522
  • [32] An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register
    Prince, Femke H. M.
    de Bekker-Grob, Esther W.
    Twilt, Marinka
    van Rossum, Marion A. J.
    Hoppenreijs, Esther P. A. H.
    ten Cate, Rebecca
    Koopman-Keemink, Yvonne
    Gorter, Simone L.
    Raat, Hein
    van Suijlekom-Smit, Lisette W. A.
    RHEUMATOLOGY, 2011, 50 (06) : 1131 - 1136
  • [33] Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry
    Correll, Colleen K.
    Stryker, Scott
    Collier, David
    Phillips, Thomas A.
    Dennos, Anne C.
    Balevic, Stephen J.
    Beukelman, Timothy
    CARRA Registry Investigators
    RMD OPEN, 2023, 9 (02):
  • [34] Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis
    Hoshino, Motoaki
    Yoshio, Taku
    Onishi, Sachiko
    Minota, Seiji
    MODERN RHEUMATOLOGY, 2012, 22 (04) : 532 - 540
  • [35] Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis
    Foeldvari, Ivan
    Tzaribachev, Nikolay
    Cron, Randy Q.
    PEDIATRIC RHEUMATOLOGY, 2014, 12
  • [36] MR EVALUATION OF THE TEMPOROMANDIBULAR-JOINT IN JUVENILE RHEUMATOID-ARTHRITIS
    TAYLOR, DB
    BABYN, P
    BLASER, S
    SMITH, S
    SHORE, A
    SILVERMAN, ED
    CHUANG, S
    LAXER, RM
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1993, 17 (03) : 449 - 454
  • [37] Comparison of Long-Term Clinical Outcome With Etanercept Treatment and Adalimumab Treatment of Rheumatoid Arthritis With Respect to Immunogenicity
    Krieckaert, Charlotte L.
    Jamnitski, Anna
    Nurmohamed, Michael T.
    Kostense, Piet J.
    Boers, Maarten
    Wolbink, Gertjan
    ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 3850 - 3855
  • [38] Comparison of joint destruction between standard- and low-dose etanercept in rheumatoid arthritis from the Prevention of Cartilage Destruction by Etanercept (PRECEPT) study
    Tada, Masahiro
    Koike, Tatsuya
    Okano, Tadashi
    Sugioka, Yuko
    Wakitani, Shigeyuki
    Fukushima, Kenzo
    Sakawa, Akira
    Uehara, Kazunori
    Inui, Kentaro
    Nakamura, Hiroaki
    RHEUMATOLOGY, 2012, 51 (12) : 2164 - 2169
  • [39] Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study
    Dallocchio, Aymeric
    Canioni, Daniele
    Ruemmele, Frank
    Duquesne, Agnes
    Scoazec, Jean-Yves
    Bouvier, Raymonde
    Paraf, Francois
    Languepin, Jeanne
    Wouters, Carine H.
    Guillot, Marcel
    Quartier, Pierre
    Bader-Meunier, Brigitte
    RHEUMATOLOGY, 2010, 49 (09) : 1694 - 1698
  • [40] Etanercept response in patients with rheumatoid arthritis after secondary loss of efficacy of infliximab
    Matsuno, Hiroaki
    MODERN RHEUMATOLOGY, 2010, 20 (06) : 561 - 565
12345